(Q35091031)

6 August 2017

1 reference

title

Newly available treatments for psoriatic arthritis and their impact on skin psoriasis (English)

1 reference

6 August 2017

1 reference

Hassan Galadari

1

1 reference

6 August 2017

Brian Fuchs

series ordinal

2

1 reference

6 August 2017

Mark Lebwohl

series ordinal

3

1 reference

6 August 2017

language of work or name

1 reference

1 March 2003

1 reference

International Journal of Dermatology

6 August 2017

published in

1 reference

6 August 2017

volume

42

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

231-237

1 reference

An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01449.X

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01449.X

Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01449.X

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2003.01449.X

10.1046/J.1365-4362.2003.01449.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference